PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2006. Start Trial.
Date Value
November 13, 2026 2.188
November 12, 2026 2.188
November 11, 2026 2.175
November 10, 2026 2.175
November 09, 2026 2.175
November 06, 2026 2.136
November 05, 2026 2.145
November 04, 2026 2.070
November 03, 2026 2.052
November 02, 2026 2.068
October 30, 2026 2.039
October 29, 2026 1.878
October 28, 2026 1.868
October 27, 2026 1.885
October 26, 2026 1.917
October 23, 2026 1.845
October 22, 2026 1.845
October 21, 2026 1.86
October 20, 2026 1.813
October 19, 2026 1.773
October 16, 2026 1.775
October 15, 2026 1.775
October 14, 2026 1.766
October 13, 2026 1.735
October 12, 2026 1.808
Date Value
October 09, 2026 1.785
October 08, 2026 1.806
October 07, 2026 1.769
October 06, 2026 1.751
October 05, 2026 1.774
October 02, 2026 1.762
October 01, 2026 1.816
September 30, 2026 1.825
September 29, 2026 1.812
September 28, 2026 1.828
September 25, 2026 1.807
September 24, 2026 1.846
September 23, 2026 1.829
September 22, 2026 1.871
September 21, 2026 1.929
September 18, 2026 1.896
September 17, 2026 1.932
September 16, 2026 1.932
September 15, 2026 1.932
September 14, 2026 1.932
September 11, 2026 1.899
September 10, 2026 1.973
September 09, 2026 1.921
September 08, 2026 1.968
September 04, 2026 2.017

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
AstraZeneca PLC 9.522
GSK Plc 2.285
Novartis AG 5.556
Pfizer Inc. 2.596
Roche Holding AG 5.055

PS Ratio Related Metrics